CONConcentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, NEC
- Revenue
- $2.2B
- 14% YoY
- Operating margin
- 15.4%
- 3.7% YoY
- EBITDA
- $410M
- 10% YoY
- Market cap
- $5.1B
- Employees
- 13,000
- $166K revenue each
- Net debt / EBITDA
- 3.4×
- $1.4B net debt
- AI in 10-K
- 0.7
- mentions per 10K words
Takeover score 2 of 13
Fixable underperformance 1 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo168% of net incomeCash flow under 80% of net income
- Dilutive SBCNo0% of revenueOver 10% of revenue
- Payouts exceed cash flowNo20% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyYes49% of assetsOver 40% of assets
- Shareholder dissentNo96% lowest supportAny vote under 80% support
Buyer economics 0 of 4
- Low revenue per employeeNo$166K · 33rd pctBottom quartile of its SIC industry
- Quiet on AINo0.7 per 10K words · 26th pctBottom quartile of AI mentions in 10-Ks
- Net cashNo3.4× EBITDA net debtMore cash than debt, positive EBITDA
- Buyout-sizedNo$5.1B market capMarket cap $500M–$5B
Catalysts 1 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingYes−$15M netNet sales over $10M in 12 months
Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|
| Revenue | $1.7B | $1.8B | $1.9B | $2.2B | 14% |
| Operating income | $259M | $288M | $305M | $334M | 9.6% |
| Net income | $167M | $180M | $167M | $166M | 0.1% |
| Operating cash flow | $274M | $234M | $275M | $279M | 1.7% |
| Capex | $46M | $65M | $64M | $82M | 28% |
| Stock-based comp | $2M | $651K | $2M | $10M | 351% |
| Buybacks | $0 | $0 | $15M | $22M | 46% |
| Dividends | $0 | $0 | $8M | $32M | 303% |
Deal filings
None.
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| Sep 1, 2026 | ORTENZIO ROBERT A | SCHEDULE 13D/A | 5.2% | Passive |
| Aug 24, 2026 | ORTENZIO ROBERT A | SCHEDULE 13D/A | 5.3% | Passive |
| Nov 26, 2025 | ORTENZIO ROBERT A | SCHEDULE 13D/A | 6.4% | Passive |
| Mar 4, 2025 | ORTENZIO ROBERT A | SCHEDULE 13D/A | 6.4% | Passive |
| Mar 4, 2025 | ORTENZIO ROCCO A | SCHEDULE 13D/A | 2.6% | Passive |
| Dec 3, 2024 | ORTENZIO ROBERT A | SC 13D | 5.7% | Passive |
| Dec 3, 2024 | ORTENZIO ROCCO A | SC 13D | 5.0% | Passive |
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $15M · 4
- Net
- −$15M
Pay vs performance
No pay-versus-performance disclosure yet.